KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -50.0% | 14,946 | -27.2% | 0.00% | – |
| Q2 2022 | $6,000 | -82.4% | 20,540 | -15.7% | 0.00% | – |
| Q1 2022 | $34,000 | +61.9% | 24,359 | +39.8% | 0.00% | – |
| Q4 2021 | $21,000 | -60.4% | 17,429 | -13.4% | 0.00% | – |
| Q3 2021 | $53,000 | -39.1% | 20,135 | +23.0% | 0.00% | – |
| Q2 2021 | $87,000 | -45.6% | 16,364 | -30.8% | 0.00% | – |
| Q4 2020 | $160,000 | +272.1% | 23,663 | +309.5% | 0.00% | – |
| Q3 2020 | $43,000 | -30.6% | 5,778 | -2.2% | 0.00% | – |
| Q2 2020 | $62,000 | +29.2% | 5,910 | -54.3% | 0.00% | – |
| Q4 2019 | $48,000 | +152.6% | 12,932 | +154.5% | 0.00% | – |
| Q3 2019 | $19,000 | +137.5% | 5,082 | +536.0% | 0.00% | – |
| Q3 2018 | $8,000 | -69.2% | 799 | -57.4% | 0.00% | – |
| Q2 2018 | $26,000 | – | 1,875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |